Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naïve patients with type 2 diabetes: a randomized, double-blind, 6-month study. (Q51328925)
Jump to navigation
Jump to search
scientific article published on 12 February 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naïve patients with type 2 diabetes: a randomized, double-blind, 6-month study. |
scientific article published on 12 February 2014 |
Statements
1 reference
Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naïve patients with type 2 diabetes: a randomized, double-blind, 6-month study. (English)
1 reference
R E Pratley
1 reference
P Fleck
1 reference
C Wilson
1 reference
12 February 2014
1 reference
16
1 reference
7
1 reference
613-621
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference